Cargando…
Cell Division Cycle Associated 8 Is a Key Regulator of Tamoxifen Resistance in Breast Cancer
PURPOSE: Breast cancer (BC) is one of the most common malignancies globally, and millions of women worldwide are diagnosed with BC every year. Up to 70% of BC patients are estrogen receptor (ER)-positive. Numerous studies have shown that tamoxifen has a significant therapeutic effect on both primary...
Autores principales: | Yu, Dehai, Shi, Libo, Bu, Yuhui, Li, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597414/ https://www.ncbi.nlm.nih.gov/pubmed/31281726 http://dx.doi.org/10.4048/jbc.2019.22.e29 |
Ejemplares similares
-
Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012) -
Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis
por: Wang, Xiaopeng, et al.
Publicado: (2021) -
Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to
Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021) -
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
por: Zhang, Hongkai, et al.
Publicado: (2020) -
Association of tamoxifen resistance and lipid reprogramming in breast cancer
por: Hultsch, Susanne, et al.
Publicado: (2018)